Eli Lilly Director J. Erik Fyrwald Acquires Shares via Compensation Deferral
ELI LILLY & Co
Subscribe to track LLY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
# Insider Transaction Report: ELI LILLY & Co ($LLY)
**Date:** September 21, 2026 | **Filing Date:** September 22, 2026
### Insider Information
- **Name:** J. Erik Fyrwald
- **Relationship:** Director
### Transaction Summary
- **Type:** Acquisition (Award/Grant under Directors' Deferral Plan)
- **Shares:** 8.513
- **Price Per Share:** $1,164.89
- **Total Transaction Value:** $9,916.71
- **Ownership After Transaction:** 75,536.1308 shares (Direct)
### Trading Significance
- **Significance:** Low (Routine acquisition of stock units in lieu of director cash compensation)
Comprehensive Analysis
Transaction Overview
On September 21, 2026, J. Erik Fyrwald, a Director at Eli Lilly & Co ($LLY), acquired 8.513 shares of Common Stock at an effective price of $1,164.89 per share, totaling approximately $9,916.71. Following this transaction, Fyrwald directly holds 75,536.1308 shares of Lilly common stock.
Transaction Nature and Mechanism
According to the footnote disclosures, the shares were acquired under code 'A' through the Lilly Directors' Deferral Plan. At the director's election, these shares were deferred in lieu of cash retainer/compensation fees and structured as stock units, to be settled in common stock upon separation from board service.
Market and Trading Implications
- Low Strategic Significance: This transaction represents an elective compensation conversion rather than an open-market purchase or discretionary liquidity event.
- Alignment of Interests: Converting cash director compensation into deferred equity units reinforces long-term alignment with shareholders, though the transaction size is negligible relative to the director's existing position of over 75,000 shares.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.